I thought the Options AS2O are worth a thread of there own (as I'm holding lots of them).
I bought options as they are cheaper than heads.
Face value means I can get more exposure with the same money...
And with a 25 cent strike price.. they are usually much better value than heads too.
Askari have a lot going on right now... and a lot of news expected this FY.
Two of the things on the cards are:
1) A spin off of the non Lithium assets into a separate Company via an IPO.
2) The need for more Capital to continue the strong growth.
My question is this.
CRs are not ideal, and management have a good track record if avoiding dilution.
So....
If the spin off is structured in a way that encourages Options holders to convert AS2O in order to get the free shares in the new IPO...
AND the IPO raises some money too....
Will that be enough to keep the coffers full until the next deal can be struck... and avoid dilution via a CR?
Looking forward to your thoughts everybody.
Thanks
Coco
- Forums
- ASX - By Stock
- Askari Options
AS2
askari metals limited
Add to My Watchlist
0.00%
!
0.6¢

I thought the Options AS2O are worth a thread of there own (as...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.425M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.5¢ | $3.185K | 540K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 633332 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1595482 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 633332 | 0.006 |
14 | 5839534 | 0.005 |
4 | 3440000 | 0.004 |
4 | 4033336 | 0.003 |
3 | 2300001 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1595482 | 9 |
0.008 | 6694657 | 7 |
0.009 | 2812500 | 2 |
0.010 | 2740742 | 7 |
0.012 | 545262 | 5 |
Last trade - 15.53pm 18/06/2025 (20 minute delay) ? |
Featured News
AS2 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online